Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: April 29, 2015
Headquarters: 9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121
Founder-Led: Yes — Brian Lian (President, CEO & Director)
Key Metrics
Current Price
$34.17
Market Cap
$4.01B
Float
113.7M
Shares Outstanding
116.7M
vs. Analyst Target
+170.4% to analyst PT
Dividend Rate
None
Analyst Target Price
$92.39 (19 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$10,731
-$39.5M
$10,731
$3.8M
2021
$10,701
-$55.0M
-$296,000
-$54.7M
2022
N/A
-$68.9M
-$291,000
-$68.5M
2023
N/A
-$85.9M
-$292,000
-$101M
2024
N/A
-$110M
-$346,000
-$110M
2025
N/A
-$360M
-$431,000
-$359M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
N/A
-$90.8M
Dec 2025
N/A
-$158M
Mar 2026
N/A
-$158M
Jun 2026
N/A
-$128M
Ownership & Float
Insider Ownership
3.1%
Institutional Ownership
66.1%
Short Float
19.8%
% of All Funds Holding
4.92%
Number of Funds Holding
433
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$35.35
Near-term / short-term trend
Weekly
40-Week SMA
$33.41
Medium-term trend
Weekly
80-Week SMA
$31.56
Cyclical trend (business cycle)
Weekly
200-Week SMA
$32.65
Secular trend (multi-year)
Monthly
10-Month SMA
$33.62
Near-term monthly trend
Monthly
20-Month SMA
$31.41
Medium-term monthly trend
Monthly
40-Month SMA
$36.86
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$26.40
support
1.10x
9 months ago
$24.20
support
1.22x
15 months ago
$73.00
resistance
1.21x
20 months ago
Historical Earnings Reactions (46 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.66%
0.00%
43.48%
18.20%
-15.65%
1 Day
1.53%
-0.12%
50.00%
28.31%
-10.70%
1 Week
2.89%
2.56%
54.35%
30.11%
-18.80%
2 Weeks
3.56%
2.99%
60.87%
52.86%
-34.35%
1 Month
5.77%
-1.57%
48.89%
174.10%
-45.96%
Next earnings: October 17, 2026 (51 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-0.7%
45.5%
11
Feb
22.1%
54.5%
11
Mar
-3.5%
27.3%
11
Apr
1.4%
45.5%
11
May
7.7%
33.3%
12
Jun
-0.4%
41.7%
12
Jul
-0.1%
50.0%
12
Aug
1.2%
45.5%
11
Sep
5.4%
27.3%
11
Oct
5.2%
36.4%
11
Nov
-1.8%
45.5%
11
Dec
14.3%
54.5%
11
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.28%
46.2%
533
Tuesday
-0.01%
41.5%
586
Wednesday
0.08%
47.9%
584
Thursday
0.51%
46.9%
574
Friday
0.25%
49.1%
570
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 66.1%
Insider Transactions — Smart Summary
Total insider ownership: 3.1%
Founder-led management: Brian Lian (President, CEO & Director)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Viking Therapeutics Inc
(VKTX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.